Author(s) |
Hall AS, Murray GD, Ball SG
|
 |
Title(s) |
Follow-up study of patients randomly allocated ramipril or placebo for heart failure after myocardial infarction: AIRE Extension (AIREX) study
|
|
Reference(s) |
Lancet 1997;349:1493-7
|
|
Disease |
AMI with heart failure
|
|
Purpose |
To assess the long-term (3 years after the end of AIRE) survival benefits of ramipril compared to placebo in the UK patients from the AIRE study
|
|
Study design |
Retrospective, controlled
|
|
Follow-up |
3 years
|
|
Patients |
603 patients (302 initially on ramipril, 301 initially on placebo)
|
|
Treatment regimen |
See treatment for the AIRE study
|
|
Results |
Death from all causes had occurred in 117/301 previously placebo-treated patients and 83/302 previously ramipril-treated patients. This is a statistically significant relative risk reduction of 36%
|
|
